Drug profile · INN
diphenylpyraline hydrochloride
HISPRIL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
diphenylpyraline hydrochloride (HISPRIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN diphenylpyraline hydrochloride
Brand HISPRIL
Route ORAL
Formulation CAPSULE, EXTENDED RELEASE
Frequently asked questions
What is diphenylpyraline hydrochloride?
diphenylpyraline hydrochloride (HISPRIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for diphenylpyraline hydrochloride?
HISPRIL is a marketed brand name for diphenylpyraline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diphenylpyraline hydrochloride?
diphenylpyraline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.